Enstar Group Limited Reports Third Quarter Results
Net Loss of $48.9 million for the Nine Months Ended September 30, 2018 Non-GAAP Operating Income of $120.0 million for the […]
Net Loss of $48.9 million for the Nine Months Ended September 30, 2018 Non-GAAP Operating Income of $120.0 million for the […]
EDGEWOOD, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero®”) (NYSE American: CVU) today announced financial results […]
PLANO, Texas, Nov. 08, 2018 (GLOBE NEWSWIRE) — Denbury Resources Inc. (NYSE: DNR) (“Denbury” or the “Company”) today announced net […]
SHANGHAI, China, Nov. 08, 2018 (GLOBE NEWSWIRE) — WABCO Holdings Inc. (NYSE: WBC) (www.wabco-auto.com), the leading global supplier of braking […]
WALTHAM, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) — ‒ Histogenics and FDA Continue Discussions on NeoCart® Phase 3 Data and Potential […]
CALGARY, Alberta, Nov. 08, 2018 (GLOBE NEWSWIRE) — STEP Energy Services Ltd. (the “Company” or “STEP”) is pleased to announce […]
Eric Rosenfeld Named Chairman Emeritus EDGEWOOD, N.Y., Nov. 08, 2018 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero”) (NYSE American: […]
Tel Aviv, Israel, Nov. 08, 2018 (GLOBE NEWSWIRE) — Elbit Imaging Ltd. (“EI” or the “Company”) (TASE, NASDAQ: EMITF) announced […]
SINGAPORE, Nov. 08, 2018 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (NASDAQ:ASLN, TPEx:6497), a clinical-stage biopharmaceutical company targeting cancers that are both […]
WALTHAM, Mass. and LONDON, Nov. 08, 2018 (GLOBE NEWSWIRE) — Nightstar Therapeutics plc (NASDAQ:NITE), a clinical-stage gene therapy company developing […]